CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2
2008

Effects of WIN 55,212-2 on Excitatory Synaptic Transmission in the Hippocampus

publication Evidence: high

Author Information

Author(s): Németh Beáta, Ledent Catherine, Freund Tamás F., Hájos Norbert

Primary Institution: Institute of Experimental Medicine, Hungarian Academy of Sciences

Hypothesis

How does the synthetic cannabinoid WIN 55,212-2 affect excitatory postsynaptic currents in the hippocampus?

Conclusion

WIN 55,212-2 reduces glutamate release in the hippocampus through both CB1 receptor-dependent and independent mechanisms.

Supporting Evidence

  • WIN 55,212-2 reduced the amplitude of EPSCs in a dose-dependent manner.
  • The cannabinoid's effect was still significant even when CB1 receptors were blocked.
  • WIN 55,212-2's action was mediated through presynaptic mechanisms.

Takeaway

WIN 55,212-2 is a synthetic cannabinoid that can lower the signals between brain cells in the hippocampus, which is important for learning and memory.

Methodology

The study used whole-cell patch-clamp recordings from CA1 pyramidal cells in rat and mouse brain slices to measure the effects of WIN 55,212-2 on excitatory postsynaptic currents.

Participant Demographics

Male Wistar rats (14–18 days old) and wild type and CB1R knockout mice (15–25 days old, CD1 strain) were used.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1016/j.neuropharm.2007.07.003

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication